We found that the JAK–STAT signaling pathway, the P53 signaling pathway, the TGF-β signaling pathway, and the WNT signaling pathway are activated in higher-CKAP2L ccRCC samples (Figure 4B). This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.